➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Harvard Business School
Boehringer Ingelheim
Moodys
AstraZeneca

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

Litigation Details for Teamsters Local 404 Health Services & Insurance Plan v. King Pharmaceuticals, Inc. (S.D.N.Y. 2015)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in Teamsters Local 404 Health Services & Insurance Plan v. King Pharmaceuticals, Inc.
The small molecule drug covered by the patents cited in this case is ⤷  Free Forever Trial .

Details for Teamsters Local 404 Health Services & Insurance Plan v. King Pharmaceuticals, Inc. (S.D.N.Y. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-07-16 14 alleging infringement of U.S. Patent No. 7,449,012 (the “‘0 12 Patent”). King later amended the complaint…constitutes an act of patent infringement allowing the branded company to commence patent infringement litigation…a claim of infringement of U.S. Patent No. 7,794,432 (the “‘432 Patent”).16 The suit triggered an automatic… prevail on the ‘012 Patent ciaims, Respondent King later dropped the ‘432 Patent infringement claims.… of a substantial question of federal patent law, in that patent law is a necessary element of one of External link to document
2015-08-03 18 obtained U.S. Patent Nos. 7,449,012 B2 (the “‘012 patent”) and 7,794,432 B2 (the “‘432 patent”), which cover…EpiPen® patents. Pfizer holds multiple patents covering EpiPen®, namely the ‘012 patent and the…infringement of the ‘012 patent, and later added a claim that Teva infringed the ‘432 patent. As Petitioner concedes…of a substantial question of federal patent law, in that patent law is a necessary element of one of … validity or scope of a patent present a substantial issue of federal patent law. U.S. Valves, Inc. v External link to document
2015-06-25 8 obtained U.S. Patent Nos. 7,449,012 B2 (the “‘012 patent”) and 7,794,432 B2 (the “‘432 patent”), which cover… and ‘432 patents. Id. ¶ 29. Respondents King and Meridian thereafter sued Teva for patent infringement…October 2010 during the pendency of the EpiPen® patent lawsuit. See Decl. of Patrick J. Coughlin in…Respondents asserted infringement of the ‘012 and ‘432 patents. Id. ¶ 26. The parties settled in April 2012 before…decision was rendered by the district court (“EpiPen® Patent Settlement”). Id. ¶ 32. On April 30, 2015 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Medtronic
Merck
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.